Orchard Therapeutics vs Regenxbio
Orchard Therapeutics vs Regenxbio, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Orchard Therapeutics is on 51/100 and Regenxbio on 55/100.
Where each one leads
Orchard Therapeutics
- domain rating: 60/100 against 54/100
Regenxbio
- our overall score: 55/100 against 51/100
- headcount: 396 against 248
- funding raised: $180M against $125M
At a glance
| Measure | Orchard Therapeutics | Regenxbio |
|---|---|---|
| What it is | Gene therapy company developing treatments for rare inherited diseases. | Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Software |
| Founded | 2015 | 2008 |
| Headquarters | Boston, United States | Rockville, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Orchard Therapeutics | Regenxbio |
|---|---|---|
| Employees | 248 | 396 |
| Total funding | $125M | $180M |
| Latest round | IPO | Funding Round |
| LinkedIn followers | 54,964 | 49,536 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Orchard Therapeutics | Regenxbio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 55/100 |
| Traction | 60/100 | 60/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 25/100 | 24/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (36/100) |
| Domain ratingLink authority, 0-100 | 60/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Orchard Therapeutics | Regenxbio |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
Orchard Therapeutics vs Regenxbio: common questions
Which is better, Orchard Therapeutics or Regenxbio?
On our 0-100 score Regenxbio rates higher (55/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Orchard Therapeutics and Regenxbio compare on the numbers?
Orchard Therapeutics leads on domain rating (60/100 against 54/100). Regenxbio leads on our overall score (55/100 against 51/100), headcount (396 against 248), funding raised ($180M against $125M).
Read the full Orchard Therapeutics review and pricing or the Regenxbio review and pricing. You can also browse other Orchard Therapeutics alternatives we track.